Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Orthogon Therapeutics

Request full access

Meeting a critical need in translational drug discovery by bridging frontier research with formal drug development

Canton, United StatesFounded 2006Biotech & Life Sciences

About Orthogon Therapeutics

Orthogon Therapeutics is a biopharmaceutical company that specializes in the development of antiviral medicines for challenging drug targets. The company's primary focus is on creating small molecule therapies, with a lead candidate being the first-ever oral treatment for BK polyomavirus, a significant viral complication for transplant recipients.

By leveraging advanced structure-based drug design and biophysics, Orthogon Therapeutics designs and develops its therapies. The company's business model is centered on research and development, with the goal of bringing new antiviral drugs to market. Its target market includes transplant patients and others who are susceptible to opportunistic viral infections. The company generates revenue through financing and partnerships to advance its drug candidates through the development and clinical trial process.

Source: Dealroom company data

At a glance

Status
Operational
Employees
3
Open positions
None listed
Dealroom signal
63.1/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VC✓Equity / VC May 2026 $11M $44M Undisclosed ↗
EARLY VC✓Equity / VC Dec 2024 $5.2M $40M Undisclosed ↗
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Orthogon Therapeutics website traffic

Latest recorded traffic for Orthogon Therapeutics is 20 monthly website visits, down 99.1% over the last three months. Orthogon Therapeutics's team grew 0% over the past year.

Latest monthly visits20 3-month web change-99.1% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Orthogon Therapeutics in the Canton ecosystem

Live from Dealroom

The Orthogon Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Otrfoundation

Other known investors1 additional known investor

  • Startup Leadership Program- SF
Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Canton HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Orthogon Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Orthogon Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.